[go: up one dir, main page]

AR071834A1 - Sistema polimerico de lagrimas artificiales - Google Patents

Sistema polimerico de lagrimas artificiales

Info

Publication number
AR071834A1
AR071834A1 ARP090101464A ARP090101464A AR071834A1 AR 071834 A1 AR071834 A1 AR 071834A1 AR P090101464 A ARP090101464 A AR P090101464A AR P090101464 A ARP090101464 A AR P090101464A AR 071834 A1 AR071834 A1 AR 071834A1
Authority
AR
Argentina
Prior art keywords
formulations
polymer system
artificial tears
borate
artificial
Prior art date
Application number
ARP090101464A
Other languages
English (en)
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40886688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR071834(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of AR071834A1 publication Critical patent/AR071834A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se divulgan formulaciones de l grimas artificiales y formulaciones oft lmicas adecuadas para el suministro de f rmacos. Las formulaciones comprenden galactomananos tales como guar o hidroxipropilguar y una fuente de borato tal como  cido borico. Las formulaciones tambien comprenden un cis-diol tal como sorbitol que interfiere en la formacion de enlaces cruzados de galactomanano y borato. Las formulaciones est n sustancialmente libres de cationes divalentes.
ARP090101464A 2008-04-26 2009-04-24 Sistema polimerico de lagrimas artificiales AR071834A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4817508P 2008-04-26 2008-04-26

Publications (1)

Publication Number Publication Date
AR071834A1 true AR071834A1 (es) 2010-07-21

Family

ID=40886688

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP090101464A AR071834A1 (es) 2008-04-26 2009-04-24 Sistema polimerico de lagrimas artificiales
ARP180102103 AR112286A2 (es) 2008-04-26 2018-07-26 Sistema polimérico de lágrimas artificiales

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP180102103 AR112286A2 (es) 2008-04-26 2018-07-26 Sistema polimérico de lágrimas artificiales

Country Status (17)

Country Link
US (3) US20090270345A1 (es)
EP (1) EP2278954B1 (es)
JP (1) JP5659149B2 (es)
KR (1) KR101592872B1 (es)
CN (1) CN102046150B (es)
AR (2) AR071834A1 (es)
AU (1) AU2009240488B2 (es)
BR (1) BRPI0910717A2 (es)
CA (1) CA2722508C (es)
CL (1) CL2009000985A1 (es)
ES (1) ES2818619T3 (es)
MX (1) MX2010011736A (es)
NZ (1) NZ589323A (es)
TW (1) TWI526213B (es)
UY (1) UY31785A1 (es)
WO (1) WO2009132294A1 (es)
ZA (1) ZA201007644B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220431B2 (en) * 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
US20050137166A1 (en) * 2003-12-19 2005-06-23 Alcon, Inc. Use of cooling agents to relieve mild ocular irritation and enhance comfort
ES2818619T3 (es) * 2008-04-26 2021-04-13 Alcon Inc Sistema de lagrima artificial polimérico
TWI547522B (zh) 2009-07-07 2016-09-01 愛爾康研究有限公司 環氧乙烷環氧丁烷嵌段共聚物組成物
TWI478730B (zh) * 2009-12-03 2015-04-01 Alcon Res Ltd 眼科乳劑
SI2965749T1 (sl) * 2009-12-03 2018-09-28 Novartis Ag Suspenzije nanodelcev, ki vsebujejo karboksivinilni polimer
SG10201804305SA (en) * 2010-05-05 2018-06-28 Alcon Res Ltd Stabilized ophthalmic galactomannan formulations
UA113434C2 (uk) * 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
US20130344619A1 (en) 2012-06-21 2013-12-26 Lightship Medical Limited Glucose sensor
US11730699B2 (en) 2018-02-21 2023-08-22 Alcon Inc. Lipid-based ophthalmic emulsion
TWI884130B (zh) 2018-02-21 2025-05-21 瑞士商愛爾康公司 基於脂質的眼用乳劑
JP6705495B1 (ja) * 2018-12-26 2020-06-03 株式会社Ｊｖｃケンウッド 車両用記録制御装置、車両用記録装置、車両用記録制御方法およびプログラム
US12329763B2 (en) * 2019-03-04 2025-06-17 Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. Composition of lanosterol prodrug compound, preparation method therefor and use thereof
TWI757773B (zh) * 2019-06-28 2022-03-11 瑞士商愛爾康公司 眼用組成物
WO2021053586A1 (en) 2019-09-18 2021-03-25 Alcon Inc. Wet-packed soft hydrogel ocular inserts
CN114191378A (zh) * 2021-11-23 2022-03-18 温州医科大学附属眼视光医院 一种地夸磷索缓释凝胶及其制备方法与应用
US20250276007A1 (en) 2024-03-04 2025-09-04 Alcon Inc. Carbamoylphenylboronic acid-containing acrylic monomers and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
GB1593954A (en) * 1977-01-31 1981-07-22 American Home Prod Xanthan gum or locust bean gum topical therapeutic compositions
US5505953A (en) * 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
PT999854E (pt) * 1997-07-29 2003-12-31 Alcon Mfg Ltd Sistemas viscoelasticos comutaveis contendo polimeros de galactomanano e borato
WO1999006023A1 (en) * 1997-07-29 1999-02-11 Alcon Laboratories, Inc. Ophthalmic compositions containing galactomannan polymers and borate
IT1298758B1 (it) * 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US20050129771A1 (en) * 2003-12-11 2005-06-16 Alcon, Inc. Ophthalmic compositions containing a polysaccharide/borate gelling system
DE102006031500A1 (de) 2006-07-06 2008-04-17 Henkel Kgaa O/W-Emulsion
WO2008036855A2 (en) * 2006-09-21 2008-03-27 Alcon Research, Ltd. Self-preserved aqueous pharmaceutical compositions
US9096819B2 (en) * 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
US8119112B2 (en) * 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
ES2818619T3 (es) * 2008-04-26 2021-04-13 Alcon Inc Sistema de lagrima artificial polimérico
SG10201804305SA (en) * 2010-05-05 2018-06-28 Alcon Res Ltd Stabilized ophthalmic galactomannan formulations

Also Published As

Publication number Publication date
KR101592872B1 (ko) 2016-02-12
ES2818619T3 (es) 2021-04-13
US8685945B2 (en) 2014-04-01
TWI526213B (zh) 2016-03-21
AU2009240488B2 (en) 2013-02-21
BRPI0910717A2 (pt) 2015-09-29
UY31785A1 (es) 2009-08-03
NZ589323A (en) 2012-04-27
EP2278954B1 (en) 2020-08-26
US20140161760A1 (en) 2014-06-12
US20090270345A1 (en) 2009-10-29
US20120070402A1 (en) 2012-03-22
MX2010011736A (es) 2011-01-21
JP5659149B2 (ja) 2015-01-28
WO2009132294A1 (en) 2009-10-29
AU2009240488A1 (en) 2009-10-29
CN102046150B (zh) 2013-07-24
CN102046150A (zh) 2011-05-04
KR20110007228A (ko) 2011-01-21
JP2011518842A (ja) 2011-06-30
CA2722508C (en) 2016-08-16
CA2722508A1 (en) 2009-10-29
CL2009000985A1 (es) 2010-01-15
EP2278954A1 (en) 2011-02-02
TW200948367A (en) 2009-12-01
ZA201007644B (en) 2011-12-28
US9259472B2 (en) 2016-02-16
AR112286A2 (es) 2019-10-09

Similar Documents

Publication Publication Date Title
AR071834A1 (es) Sistema polimerico de lagrimas artificiales
MX342187B (es) Dispositivo de distribución de fibra óptica.
MX2015007620A (es) Aplicador y capsula para tal aplicador.
BR112014027582A2 (pt) composições oftalmicas com proteção e retenção de dessecação aperfeiçoada
PH12015502729A1 (en) Personal care compositions and articles
MX2012012826A (es) Formulaciones de galactomanana oftalmicas estabilizadas.
MX341955B (es) Articulos retrorreflectantes que incluyen areas opticamente activas y areas opticamente inactivas.
MX2012012025A (es) Articulos retrorreflectantes que incluyen areas opticamente activas y areas opticamente inactivas.
AR049929A1 (es) Metodos y composiciones para el tratamiento de afecciones oftalmicas con derivados de retinilo
BR112014032897A2 (pt) métodos e aparelho para formar baterias impressas em dispositivos oftálmicos
BR112013028306A2 (pt) plantas com características úteis e processos relacionados
BR112012026338A2 (pt) novos derivados de 3,3-dimetil tetrahidroquinolina
BR112015009600A2 (pt) piridina-2-amidas úteis como agonistas cb2
BR112014005193A2 (pt) encapsulados
UY3985Q (es) Paquete de cigarillos simulado
GT201500035A (es) Composición farmacéutica oral en forma de microesferas y proceso de elaboración
AR101236A1 (es) Composiciones para el cuidado oral
BR112015027396A8 (pt) derivados de purina como agonistas do receptor de cb2
BR112014021602A2 (pt) uso, kit e derivado de retinal sintético para melhorar a função visual em distúrbios visuais associados com a deficiência de produção endógena de retinóide
CL2012002038A1 (es) Metodo para reducir la presion intraocular que comprende la administracion en forma topica de una composicion farmaceutica que comprende 4-bromo-5-(2-imidazolin-2-ilamin)benzimidazol, en donde el ojo afectado tiene una presion intraocular inferior a la de la linea base; y articulo de elaboracion que comprende a dicha composicion.
MX2014006088A (es) Biomarcadores para canceres que responden a moduladores de la actividad de hec1.
BR112015008539A2 (pt) micro-esferas compreendendo carotenóides
CL2014003480A1 (es) Uso de huevos de ácaros astigmátidos como fuente de nutrientes para una población de agentes de control biológico de artrópodos; composición de control biológico que comprende los agentes de control y la fuente de nutrientes; y método para criar artrópodos.
NI201300144A (es) Composición farmacéutica en forma de una suspensión oral que comprende una fracción flavonoica y goma de xantano.
BR112014012325A2 (pt) fibra de poliolefina

Legal Events

Date Code Title Description
FC Refusal